Chapel Hill is a clinical research site located in Chapel Hill, North Carolina, United States 27599.
Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.
Chapel Hill has participated in 6 clinical trials with 1 currently active.
Therapeutic areas: Clostridium Difficile Infection Recurrence, Clostridium Difficile Infection, Recurrent Clostridium Difficile Infection.
Sponsors: Finch Research and Development LLC., Cornell University, Aerocrine AB.
Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Chapel Hill has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Chapel Hill has 6 clinical trials on record, with 1 currently active. Their work covers Clostridium Difficile Infection Recurrence, Clostridium Difficile Infection, Recurrent Clostridium Difficile Infection.
Yes — Chapel Hill holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.